HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF
申请人:QIU Hui
公开号:US20160264548A1
公开(公告)日:2016-09-15
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
本发明涉及吡啶、嘧啶、吡嗪和吡啶二嗪化合物及其药学上可接受的组合物,用作BTK抑制剂。
Heteroaryl compounds as BTK inhibitors and uses thereof
申请人:Merck Patent GmbH
公开号:US10329270B2
公开(公告)日:2019-06-25
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
本发明涉及可用作 BTK 抑制剂的吡啶、嘧啶、吡嗪和哒嗪化合物及其药学上可接受的组合物。
[EN] BTK INHIBITORS<br/>[FR] INHIBITEURS DE BTK
申请人:BIOGEN MA INC
公开号:WO2022032019A8
公开(公告)日:2022-03-24
5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS
申请人:Wyeth LLC
公开号:EP2229377A1
公开(公告)日:2010-09-22
[EN] HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROARYLE SERVANT D'INHIBITEURS DE LA BTK ET LEURS UTILISATIONS